Gabriele Miss

All filings by Gabriele Miss on record concern ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd."). Altogether 8 filings, all relating to 24 September 2018.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 28 September 2018, the filings show a transaction in ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd."). Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.